2007

High incidence of brain metastases found in patients with HER2 positive metastastic breast cancer.
Langkjer ST, Krøldrup L, Kristiansen C, Enevoldsen K.

09.15-09.30

The epigenetic regulation of shc1 proteins expression, and genetic variation within SHC1 gene in breast carcinomas.
Duda K, Hansen LL

09.30-09.45

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence despite postoperative radiotherapy after breast conserving surgery
Niméus E , Krogh M , Malmström P , Strand C , Fredriksson I, Karlsson P, Nordenskjöld B, Stål O, Östberg G, Peterson C, Fernö M

09.45-10.00

High TIMP-1 or PAI-1 tumor tissue levels predict resistance to chemotherapy in patients with chemo-naive metastatic breast cancer
Marie Klintman, Sidse Ø Würtz , Anne Sofie Schrohl , Mårten Fernö , Martin Malmberg, Per Malmström, Henning Mouridsen and Nils Brünner.

10.00-10.15

Plasma TIMP-1 combined with plasma CEA measurements in risk assessment for CRC. A population based, prospective study of 5,005 individuals at risk of CRC.
Nielsen HJ, Brünner N, Davis G, Jorgensen LN, Thygesen K, Hoyer U, Olsen J, Rahr HB, Laurberg S, Stieber P, Blankenstein MA, Dowell B, Doss R, King D, Christensen IJ

10.15-10.45

POSTERS & kaffe

SESSION II:
Chairmen:

Stem cells and invasion
Ole William Pedersen og Nils Brünner

10.45-11.00

Expression of the stem cell marker CD133 in glioblastoma
Eriksen K, Schrøder HD, Kristensen BW

11.00-11.15

Evidence for a stem cell hierarchy in the adult human breast: implications for breast cancer development
René Villadsen , Agla J. Fridriksdottir , Lone Rønnov-Jessen , Thorarinn Gudjonsson , Fritz Rank , Mark A. LaBarge, Mina J. Bissell , Ole W. Petersen

11.15-11.30

Inhibition of mouse uPA activity by mouse monoclonal antibodies in vitro and in vivo
Ida K. Lund, Annika Jögi, Niels Behrendt, Michael Ploug, Henrik Gårdsvoll, Leif R. Lund, John Rømer, Gunilla Høyer-Hansen.

11.30-11.45

Inhibition of the protein kinase RSK blocks the motile, invasive phenotype induced by the RAS-ERK pathway during epithelial oncogenesis
Døhn U, Nielsen JV, Winther BR, Jensen CJ, Hauge C, Thorup K, Ploug M, Taunton J, Hansen SH, Frodin M

11.45-12.30

Gårdejer Ingemann Petersen og Hustrus Fond,
Dansk Selskab for Cancerforsknings hæderpris

12.30-13.15

Frokost

13.15-13.45

POSTERS & Kaffe

SESSION III: Chairmen:

Mechanisms and experimental therapy
Paul E.G. Kristjansen og Mike Horsman

13.45-14.00

The RNF8 ubiquitin ligase regulates assembly of repair proteins at sites of DNA damage
Simon Bekker-Jensen, Niels Mailand, Helene Faustrup, Fredrik Melander, Jiri Bartek, Claudia Lukas, and Jiri Lukas

14.00-14.15

The function of normal and mutated epidermal growth factor receptors in Glioblastoma Multiforme - Establishment of an in vivo and in vitro model
Marie-Thérése Stockhausen, Mette Villingshøj, Mogens Spang-Thomsen, Helle Broholm, Michael Kosteljanetz, Hans Skovgaard Poulsen

14.15-14.30

Cytotoxic potential of a novel uPA-activity dependent and EGF receptor targeting pro-drug
Birgitte Rønø, Geun Bae Kim, Shihui Liu, Paul E. G. Kristjansen, David M. Neville, Stephen H. Leppla, Thomas H. Bugge, and John Rømer

14.30-14.45

Monoclonal antibody therapy against YKL-40 delays growth in glioblastoma xenografts
Nanna Junker, Julia S. Johansen, Paul E. G. Kristjansen and Paul Price

14.45-15.00

Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome destabilizing siramesine
Groth-Pedersen, L., Ostenfeld, M.S., Høyer-Hansen, M., Nylandsted, J. and Jäättelä, M.

15.00-15.30

POSTERS og kaffe

15.30-16.30

The DANISH CANCER SOCIETY LECTURE:
Dr. Paul Krimpenfort, The Nederlands Cancer Institute

16.30-16.45

Pause med øl/vand

16.45-16.50

Uddeling af pris for bedste foredrag
Bedømmelseskomité: Bodil Norrild og Lotte Hansen

16.50-16.55

Uddeling af pris for bedste posterpræsentation
Bedømmelseskomité: Claus Andrup Kristensen og Michael Ploug

18.30

Festmiddag